Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Retained Earnings

$8.02B

Quarterly · Period ending: · USD

BIO logo

BIO Retained Earnings

Latest reported$8.02B
BIO Quarterly Retained Earnings ($16.00M → $8.02B)
High-resolution chart · PNG

BIO retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
8,020,600,000
7,649,200,000
8,176,300,000
7,456,300,000
7,798,200,000
7,480,400,000
7,416,400,000
8,132,231,000
7,479,059,000
9,644,545,000
9,260,629,000
8,910,921,000
8,804,664,000
9,966,959,000
9,898,203,000
9,046,530,000
9,210,457,000
10,137,628,000
13,525,343,000
15,080,854,000
11,159,475,000
10,245,426,000
9,268,012,000
8,428,925,000
7,123,093,000
6,156,691,000
5,470,779,000
4,917,313,000
5,184,511,000
4,585,701,000
3,722,073,000
4,550,601,000
4,281,275,000
4,013,232,000
1,830,439,000
1,880,765,000
1,853,372,000
1,848,337,000
1,828,581,000
1,856,750,000
1,838,345,000
1,820,331,000
1,808,055,000
1,758,573,000
1,741,203,000
1,712,780,000
1,694,962,000
1,655,925,000
1,644,416,000
1,612,785,000
1,606,117,000
1,575,981,000
1,577,861,000
1,543,187,000
1,528,327,000
1,481,642,000
1,439,258,000
1,390,915,000
1,359,910,000
1,300,671,000
1,254,774,000
1,214,726,000
1,181,687,000
1,113,779,000
1,069,015,000
1,031,058,000
996,197,000
958,335,000
919,810,000
881,841,000
851,577,000
859,793,000
831,960,000
788,562,000
762,067,000
749,712,000
721,741,000
696,070,000
674,070,000
657,421,000
634,271,000
602,005,000
570,807,000
557,355,000
541,136,000
522,748,000
489,254,000
472,143,000
465,853,000
442,990,000
421,012,000
401,821,000
392,161,000
371,205,000
344,841,000
328,600,000
311,983,000
295,535,000
276,554,000
259,350,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.